Stockreport

Elevance Health targets at least $25.50 adjusted EPS for 2026 as company signals margin recovery and portfolio repositioning [Seeking Alpha]

Elevance Health, Inc.  (ELV) 
PDF CEO Gail Boudreaux emphasized that "2026 is a year of execution and repositioning," with guidance reflecting "prudent, achievable assumptions, grounded in pricing disci [Read more]